Literature DB >> 33909051

Patient-reported outcome measurement of symptom distress is feasible in most clinical scenarios in palliative care: an observational study involving routinely collected data.

Sabina Clapham1, Barbara A Daveson1, Samuel F Allingham1, Darcy Morris1, Pippa Blackburn1, Claire E Johnson1, Kathy Eagar1.   

Abstract

BACKGROUND: Implementation of routinely collected patient-reported outcome measures (PROMs) ensures patients' priorities are at the forefront of care planning and helps to standardize approaches to quality improvement. In palliative care, barriers to PROMs are widely known but what are not understood are the clinical and care settings in which patients are more likely to report and when proxy reporting is needed.
OBJECTIVE: To examine the incidence of patient-reported symptom distress compared to the incidence of proxy reporting in palliative care and influencing factors.
METHODS: A national observational study using routinely collected PROMs data with influencing factors investigated by logistic regression modelling. Participants were patients with an advanced life-limiting illness receiving palliative care in an inpatient or a community healthcare setting in Australia.
RESULTS: Sixteen thousand one hundred and fifty-eight reports of symptom distress were collected from 1117 patients seen by 21 palliative care services. The majority of respondents were diagnosed with cancer (76%), were older (≥65 years, 72%) and had nominated English as their first language (88%). The majority of symptom distress reports were completed by patients (61%). The odds of a patient providing a self-report where grater when they were receiving community versus inpatient palliative care (odds ratio (OR): 3.0; 95% confidence interval (CI): 2.25-4.01), for patients diagnosed with malignant versus non-malignant disease (OR 1.7; 95% CI: 1.26-2.31), and for those who required an urgent change in their care plan versus those whose symptoms and problems were adequately managed (OR: 1.38; 95% CI: 1.04-1.83).
CONCLUSION: Three factors are associated with an increased likelihood of patient versus proxy reporting in palliative care: healthcare setting, diagnosis, and the acuity and urgency of the patient's clinical needs. PROMs are feasible in most clinical scenarios in palliative care, including when an urgent clinical response is required.
© The Author(s) 2021. Published by Oxford University Press on behalf of International Society for Quality in Health Care.

Entities:  

Keywords:  caregivers; palliative care; patient-reported outcome measures; proxy; symptom assessment

Year:  2021        PMID: 33909051     DOI: 10.1093/intqhc/mzab075

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  4 in total

1.  Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine.

Authors:  Davide Fortin; Fabienne Marcellin; Patrizia Carrieri; Julien Mancini; Tangui Barré
Journal:  Front Public Health       Date:  2022-05-27

2.  Integrating patient- and caregiver-reported outcome measures into the daily care routines of specialised outpatient palliative care: a qualitative study (ELSAH) on feasibility, acceptability and appropriateness.

Authors:  Hannah Seipp; Jörg Haasenritter; Michaela Hach; Dorothée Becker; Dania Schütze; Jennifer Engler; Cornelia Ploeger; Stefan Bösner; Katrin Kuss
Journal:  BMC Palliat Care       Date:  2022-05-02       Impact factor: 3.113

3.  Proxy responses regarding quality of life of patients with terminal lung cancer: preliminary results from a prospective observational study.

Authors:  Tomoyuki Takura; Tomoko Koike; Yoko Matsuo; Asuko Sekimoto; Masami Mutou
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

4.  Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic Review.

Authors:  Alexander Fabian; Justus Domschikowski; Anne Letsch; Claudia Schmalz; Sandra Freitag-Wolf; Juergen Dunst; David Krug
Journal:  JAMA Netw Open       Date:  2022-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.